MENGENAI EPISOD INI

Bahasa Inggeris
Amerika Syarikat

TRANSKRIP 🔗

CARI EPISOD LEPAS

Cari episod lepas bagi 2016 ASCO Annual Meeting.

EPISOD LAIN DALAM PODCAST INI

Professor Menon speaks with ecancertv at ASCO 2016 about screening strategies to detect early stage ovarian cancer. Ovarian cancer was responsible for over 14,000 deaths in the US last year, but is often not diagnosed in stage I-III. With regular screening, such as annual ultrasound and multim ...
Dr Pal talks to ecancertv at ASCO 2016 about a study that looked at the uptake of BRCA genetic tests among young cancer survivors aged 50 or under. In particular, they compared black, hispanic, and non-hispanic white women. The study found that there were large disparities, with significantly f ...
Dr Choueiri speaks with ecancertv at ASCO 2016 about results from METEOR, a randomised phase III trial of cabozantinib for patients with advanced renal cell carcinoma (RCC), compared to everolimus. Cabozantinib displayed a significant impact on previously treated patients, improving median over ...
Dr Van Den Bent presents at ASCO 2016 about the phase III trial, which showed that patients with anaplastic glioma without 1p/19q co-deletion benefit from adjuvant chemotherapy, according to early results from a European phase III trial.
Prof Schilsky talks to ecancertv at ASCO 2016 about the latest in precision medicine.
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada ecancer.org, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.